iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas) General Information

Description

Early-Stage Cell Death Protein 1 Agonist Program is based in Bryan, Texas.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Bryan, TX
  • United States
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Corporate Office
  • Bryan, TX
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas)‘s full profile, request access.

Request a free trial

iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas)‘s full profile, request access.

Request a free trial

iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas) FAQs

  • Where is iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas) headquartered?

    iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas) is headquartered in Bryan, TX.

  • What industry is iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas) in?

    iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas)’s primary industry is Buildings and Property.

  • Is iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas) a private or public company?

    iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas) is a Private company.

  • What is the current valuation of iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas)?

    The current valuation of iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas) is .

  • What is iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas)’s current revenue?

    The current revenue for iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas) is .

  • Who are iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas)’s investors?

    iBio has invested in iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas).

  • When was iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas) acquired?

    iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas) was acquired on 25-Feb-2024.

  • Who acquired iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas)?

    iBio (Early-Stage Cell Death Protein 1 Agonist Program in Bryan, Texas) was acquired by Otsuka Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process